Notably, MTF2 was expressed lowly in breast cancer tissue samples at different clinical stages, with a decreasing trend towards the higher stages of the disease, suggesting its role in cancer initiation and progression [ 17 ].
← all excerpts
Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2.
1
—
—